Medical devices industry M&A deals in August 2020 total $17.17bn globally

Total medical devices industry M&A deals in August 2020 worth $17.17bn were announced globally, according to GlobalData’s deals database.

The value marked a decrease of 73.2% over the previous month and a rise of 153.5% when compared with the last 12-month average, which stood at $6.78bn.

Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $16.86bn. At the country level, the US topped the list in terms of deal value at $16.86bn.

In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of M&A deals activity in August 2020 was the US with 24 deals, followed by Switzerland with two and the UK with two.

In 2020, as of the end of August 2020, medical devices M&A deals worth $86.22bn were announced globally, marking an increase of 187.3% year on year.

Medical devices industry M&A deals in August 2020: Top deals

The top five medical devices industry M&A deals accounted for 99.4% of the overall value during August 2020.

The combined value of the top five medical devices M&A deals stood at $17.07bn, against the overall value of $17.17bn recorded for the month.

The top five medical devices industry deals of August 2020 tracked by GlobalData were:

1) Siemens Healthineers’ $16.4bn acquisition of Varian Medical Systems

2) The $360m acquisition of Intact Vascular by Koninklijke Philips

3) Sulzer‘s $117.95m acquisition of Haselmeier

4) The $96m asset transaction with TriReme Medical Inc. by Genesis MedTech International and G Vascular

5) Cellink’s acquisition of Scienion for $95.31m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.